复杂袖式肺叶切除术与常规肺叶切除术治疗肺癌的手术结局相当
该回顾性研究比较了2000至2015年间568例开放常规肺叶切除术(CL)与187例袖式肺叶切除术(SL)患者,其中复杂SL 81例。结果显示复杂SL组虽更多患者合并COPD、接受新辅助治疗、分期更晚且术前FEV1更低,但总体手术死亡率、术后并发症及5年生存率与CL组无显著差异。
要点
- 复杂袖式肺叶切除术的手术死亡率与常规肺叶切除术相当(均为2.8%)。
- 复杂SL组术后并发症和肺部并发症发生率与CL组无显著差异。
- 复杂SL组5年生存率56.2%,与CL组57.1%相当(P=0.888)。
核心结论
- 复杂袖式肺叶切除术的手术结局与常规肺叶切除术相当。
- 尽管复杂SL组更多患者为晚期NSCLC、术前FEV1低且合并COPD,其结局仍与CL组可比。
研究设计与样本
- 回顾性分析2000至2015年间568例开放常规肺叶切除术(仅切除1个肺叶)和187例袖式肺叶切除术患者。
- SL组分为标准SL(支气管袖式,n=106)和复杂SL(n=81),复杂SL包括支气管血管袖式(n=40)、血管袖式(n=26)、非典型支气管成形联合切除超过1个肺叶(n=12)及支气管袖式联合胸壁切除(n=3)。
主要发现
- 复杂SL组与CL组相比,COPD比例(25.9% vs 12.5%,P=0.001)、新辅助治疗比例(39.5% vs 12.0%,P<0.001)、晚期NSCLC比例(53.2% vs 33.1%,P=0.001)更高,术前FEV1更低(77.2% vs 84.3%,P=0.004)。
- 总体手术死亡率(住院或30天)为2.6%(n=20),CL组为2.8%,复杂SL组为2.8%。
- 术后并发症发生率CL组34.9%,复杂SL组39.5%(P=0.413);肺部并发症率CL组24.1%,复杂SL组27.2%(P=0.552)。
- 5年生存率CL组57.1%,复杂SL组56.2%(P=0.888)。
- 多因素分析显示TNM分期(P<0.001)和N状态(P<0.001)是生存的显著独立不良预后因素。
临床怎么用
- 对于需要行复杂袖式肺叶切除术的肺癌患者,其手术结局与常规肺叶切除术相当,可考虑作为合适患者的手术选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: No significant data are available to assess whether complex sleeve lobectomy (complex-SL) can be considered comparable to conventional lobectomy (CL) in terms of surgical outcome. The purpose of this study was to compare surgical and oncological outcomes of complex-SL with CL in patients with lung cancer. METHODS: Between 2000 and 2015, a total of 568 patients who underwent open CL (defined as resection of only 1 lobe) and 187 patients who underwent SL were analysed. The SL group was divided into 2 subgroups: standard-SL (bronchial SL, n = 106) and complex-SL (n = 81) (defined as bronchial sleeve resection together with another surgical intervention: bronchovascular SL, n = 40; vascular SL, n = 26; atypical bronchoplasty with resection of more than 1 lobe, n = 12; bronchial SL + chest wall resection, n = 3). RESULTS: The complex-SL group had more patients with chronic obstructive pulmonary disease (COPD) (25.9% vs 12.5%, P = 0.001), neoadjuvant treatment (39.5% vs 12.0%, P < 0.001), advanced-stage non-small-cell lung cancer (53.2% vs 33.1%, P = 0.001) and low preoperative forced expiratory volume in 1 s (77.2% vs 84.3%, P = 0.004) than the CL group. The overall surgical mortality (in-hospital or 30-day) was 2.6% (n = 20); it was 2.8% for CL and 2.8% for complex-SL. Postoperative complications occurred in 34.9% of the CL group and 39.5% of the complex-SL group (P = 0.413). The pulmonary complication rate was similar between the groups (24.1% for CL, 27.2% for complex-SL, P = 0.552). The 5-year survival in the CL group was 57.1%, and in the complex-SL group it was 56.2% (P = 0.888). Multivariate analysis showed that TNM stage (P < 0.001) and N status (P < 0.001) were significant and independent negative prognostic factors for survival. CONCLUSIONS: Complex-SL had a comparable outcome to CL, although the complex-SL group had more patients with advanced-stage NSCLC, low preoperative forced expiratory volume in 1 s and COPD.
引用
- Inci I, Benker M, Çitak N, et al. Complex sleeve lobectomy has the same surgical outcome when compared with conventional lobectomy in patients with lung cancer. Eur J Cardiothorac Surg. 2020. PMID: 31919516. doi:10.1093/ejcts/ezz357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。